"Brexpiprazole (Rexultiâ„¢) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"
- Conditions
- Major Depressive DisorderSchizophrenia
- Interventions
- First Posted Date
- 2020-11-24
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 300
- Registration Number
- NCT04641780
- Locations
- 🇵ðŸ‡
Otsuka (Philippines) Pharmaceutical Inc., Makati City, Metro Manila, Philippines
Study on the Efficacy and Safety of Oral Probucol Tablets in Patients With Hyperlipidemia - Post-Marketing Surveillance
Completed
- Conditions
- Hyperlipidemia
- First Posted Date
- 2016-04-06
- Last Posted Date
- 2016-04-06
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 3087
- Registration Number
- NCT02730390
Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2010-03-24
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 96
- Registration Number
- NCT01091337
- Locations
- 🇵ðŸ‡
Philippine General Hospital, Manila, Philippines
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
- First Posted Date
- 2010-02-26
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 47
- Registration Number
- NCT01076478
- Locations
- 🇵ðŸ‡
University of Santo Tomas Hospital, Manila, Philippines
Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy
- First Posted Date
- 2008-03-21
- Last Posted Date
- 2011-08-24
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 30
- Registration Number
- NCT00641004
- Locations
- 🇵ðŸ‡
University of Santo Tomas Hospital, Manila, Philippines
🇵ðŸ‡Armed Forces of the Philippines Medical Center, Quezon City, Philippines
🇵ðŸ‡Candinal Santos medical Center, San Juan City, Philippines
Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients
Phase 4
Terminated
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Otsuka Pharmaceutical, Inc., Philippines
- Target Recruit Count
- 50
- Registration Number
- NCT00394485
- Locations
- 🇵ðŸ‡
Philippine General Hospital, Manila, National Capital Region, Philippines
© Copyright 2025. All Rights Reserved by MedPath